Skip to main content
ConductScienceScienceDex

Terry Roemer

NIH Rank #5609
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 12254697Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2024

Linked Award Amount
$1.9M
Full award amounts, FY2024
Award Records
3
Records listing this PI
Award-Linked Rank
#5,609
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Terry Roemer. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Terry Roemer as a PI. Multi-PI records show the full award amount for context.

  • 5R44AI136213-06R44
    Development of a PO-administered beta-lactam-tarocin combination agent to treat methicillin susceptible and methicillin resistant Staphylococci
    Prokaryotics, Inc.
    $974.6K
    award amount
  • 5R01AI165740-02R01
    Development of a mechanistically novel Gram-negative antibiotic targeting MsbA-mediated Lipopolysaccharide Biogenesis
    Prokaryotics, Inc.
    $679.3K
    award amount
  • 5R42AI179344-02R42
    Development of a novel broad spectrum antifungal therapeutic targeting Glycosylphosphatidylinositol (GPI) biosynthesis and cell wall biogenesis
    Prokaryotics, Inc.
    $295.6K
    award amount

Award organization

Organizations that administered FY2024 awards listing Terry Roemer as a PI.

FY2024 award administered by Prokaryotics, Inc. (NJ).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Prokaryotics, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #5609
  5. 2025
    $2M Cumulative Funding
  6. 2025
    $5M Cumulative Funding
  7. 2025
    Entered Top 25% Nationally
    Ranked #2175
  8. 2025
    R01 Grant Holder

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Terry Roemer.

Andrew Nelson
Johns Hopkins University
1
shared award
Andrew Nelson
Hackensack University Medical Center
1
shared award
Arturo Casadevall
Johns Hopkins University
1
shared award
David Alland
Hackensack University Medical Center
1
shared award
David Alland
Johns Hopkins University
1
shared award
David S Perlin
Hackensack University Medical Center
1
shared award
David S Perlin
Johns Hopkins University
1
shared award
James M Balkovec
Johns Hopkins University
1
shared award
James M Balkovec
Hackensack University Medical Center
1
shared award
Richard H. Ebright
Hackensack University Medical Center
1
shared award

Explore further

Find collaborators for Terry Roemer

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →